Feature | Pharmaceuticals | October 25, 2023 | By Christine Book

Hypertrophic Cardiomyopathy Video Series with Christine E. Seidman, MD, FACC, FAHA

3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA

In a new 3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA, Managing Editor Christine Book sat down with the cardiovascular research leader to learn more about the critical work and research she is conducting in this field.

In the first of this 3-part “One on One” series, Dr. Christine Seidman — recognized as one of the world’s most respected physician scientists — delves into the research and treatments of the heart muscle disorder, hypertrophic cardiomyopathy. Watch Part 1: Hypertrophic Cardiomyopathy: One on One with a Cardiovascular Research Leader

In part 2 of DAIC’s 3-part “One on One” series with Dr. Christine Seidman, a discussion on the discovery of gene-based diagnostics at Harvard’s Seidman Lab which allowed for targeted disease treatment of hypertrophic cardiomyopathy. Watch Part 2: Hypertrophic Cardiomyopathy in Focushere.

In the third and final segment in DAIC’s “One on One” series with Dr. Christine Seidman, learn what’s on the horizon at Harvard’s Seidman Lab, and how she views the value of learning from and mentoring a new generation of researchers. Watch Part 3: Award-winning Researcher Shares Update on Hypertrophic Cardiomyopathy Work and Value of Mentoring

Related Hypertrophic Cardiomyopathy content:

Part 1: Hypertrophic Cardiomyopathy: One on One with a Cardiovascular Research Leader

Part 2: Hypertrophic Cardiomyopathy in Focus

Part 3: Award-winning Researcher Shares Update on Hypertrophic Cardiomyopathy Work and Value of Mentoring

Imbria Pharmaceuticals Completes Enrollment in the Phase 2 IMPROVE-ISCHEMIA Clinical Trial of Ninerafaxstat in Patients with Stable Angina

Results from Two Phase 3 Studies Evaluating Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy Released

First International Guidelines on Heart Muscle Diseases Published


Related Content

News | Cardiovascular Education

July 26, 2024 — VentriJect, a Danish medtech start-up seeking to revolutionize the way cardiorespiratory fitness (CRF) ...

Home July 26, 2024
Home
News | Cardiovascular Education

July 23, 2024 — The International Atherosclerosis Society (IAS) has released a clinical proceedings white paper ...

Home July 23, 2024
Home
News | Cardiovascular Education

May 31, 2024 — In the United States there are over 8 million active athletes. Given the rapid expansion of sports ...

Home May 31, 2024
Home
News | Cardiovascular Education

April 25, 2024 —Heart-Valve-Surgery.com, a leading patient advocacy group for heart valve disease, with support from ...

Home April 25, 2024
Home
News | Cardiovascular Education

March 21, 2024 — The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of ...

Home March 21, 2024
Home
Feature | Cardiovascular Education | Christine Book

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country ...

Home February 01, 2024
Home
News | Cardiovascular Education

January 15, 2024 — A public-private partnership Think Tank, scheduled for Feb. 29-March 1, will be presented by the ...

Home January 15, 2024
Home
News | Cardiovascular Education

December 4, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

Home December 04, 2023
Home
News | Cardiovascular Education

October 5, 2023 — The 2023 American College of Cardiology (ACC) Quality Summit kicks off on October 11-13 in Orlando ...

Home October 05, 2023
Home
News | Cardiovascular Education

DAIC’s award-winning editorial team delivers industry trends and technology information to the professionals who make ...

Home August 16, 2023
Home
Subscribe Now